The Technical Analyst
Select Language :
Hin Sang Group [6893.HK]

Exchange: HKSE Sector: Consumer products Industry: Household & Personal Products

Hin Sang Group Price, Forecast, Insider, Ratings, Fundamentals & Signals

Hin Sang Group is listed at the  Exchange

0.00% HKD0.310

America/New_York / 3 mai 2024 @ 03:57


Hin Sang Group: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 338.46 mill
EPS: -0.0300
P/E: -10.33
Earnings Date: Jun 25, 2024
SharesOutstanding: 1 091.80 mill
Avg Daily Volume: 0.0049 mill
RATING 2024-05-03
C+
Sell
RATINGS
Rating CashFlow: Sell
Return On Equity: Strong Sell
Return On Asset: Strong Sell
DE: Strong Buy
P/E: Strong Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset n/an/an/a
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -10.33 | sector: PE 15.57
PE RATIO: COMPANY / INDUSTRY
-0.41x
Company: PE -10.33 | industry: PE 24.95
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

HKD 0.291 - 0.329

( +/- 6.13%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price HKD0.310 (0.00% )
Volume 0.0060 mill
Avg. Vol. 0.0049 mill
% of Avg. Vol 122.08 %

Today

Intraday chart data with high, low, open and close for Hin Sang Group (International) Holding Co Ltd

Last 12 Months

Last 12 months chart data with high, low, open and close for Hin Sang Group (International) Holding Co Ltd

RSI

Last 10 Buy & Sell Signals For 6893.HK

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Hin Sang Group (International) Holding Co Ltd

6893.HK

Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, primarily engages in the manufacture, marketing, and sale of healthcare products primarily targeting at children in Hong Kong and Mainland China. The company operates through four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, Shuang Long, and King's Antiseptic brand names. The Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products under the Pahmi, Enear, Vcnic, Zici, and Sunew brand names; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the distribution and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. The Healthcare segment provides Chinese medical healthcare related services for mothers and children; develops mother and child related health products; and hospital, medical center, and related services. It is also involved in the trading of skin care, personal care, and slimming products; and property holding business. The company sells its products in Hong Kong, as well as sells through a network of distributors in the People's Republic of China and Macau. It also sells its products online. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. is a subsidiary of Genwealth Group Holding Company Limited.

Last 10 Buy Signals

Date Signal @
CLUSDMay 3 - 08:48$79.08
SPOL.OLMay 3 - 08:42NOK135.38
PRS.OLMay 3 - 08:38NOK36.00
CGOUSDMay 3 - 08:5572.91
XXL.OLMay 3 - 08:41NOK0.770
SOFF.OLMay 3 - 08:41NOK45.90
SIOFF.OLMay 3 - 08:41NOK35.15
VAR.OLMay 3 - 08:41NOK35.95
DNB.OLMay 3 - 08:41NOK196.90
BWO.OLMay 3 - 08:41NOK27.60

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.